FDA Clearance Tracker · P000025-S012
MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH MED-EL CI.STUDIO+ RELEASE VERSION 2.0 SOFTWARE
Last checked: Nov 20, 2026Latest source record: May 14, 2004 (this decision)Source: openFDAMethods & limitations
Decided
May 14, 2004
Approved
Time to decision
150 days
Received Dec 16, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000025-S012
- Device name
- MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH MED-EL CI.STUDIO+ RELEASE VERSION 2.0 SOFTWARE
- Applicant
- Med-El Corp.
- Applicant location
- Innsbruck
- Received
- Dec 16, 2003
- Decided
- May 14, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Original approval
- P000025
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
MED-EL CI.STUDIO+ RELEASE VERSION 2.0 SOFTWARE FOR THE MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM
Source documents
Other decisions for Med-El Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MED-EL CI SystemPMA supplement
P000025-S134 · Decided Nov 26, 2025 · 287 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.